A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2002
11/07/2002	CA2445382A1 Method for generating highly active human dendritic cells from monocytes
11/07/2002	CA2445376A1 Substance rkb-3564 having angiogenesis inhibitory action
11/07/2002	CA2445373A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatitis b viruses
11/07/2002	CA2445357A1 Pyrazole derived kinase inhibitors
11/07/2002	CA2445349A1 Anti-cd40 monoclonal antibody
11/07/2002	CA2445338A1 G-protein coupled receptors
11/07/2002	CA2445314A1 Supplementary immunotherapeutics to be used after lung cancer removal
11/07/2002	CA2445298A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
11/07/2002	CA2445290A1 A pharmaceutical tablet having a high api content
11/07/2002	CA2445262A1 Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide
11/07/2002	CA2444727A1 Agents for preventing postoperative recurrence of premenopausal breast cancer
11/07/2002	CA2444436A1 Dual inhibitors of pde 7 and pde 4
11/07/2002	CA2444334A1 Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents
11/07/2002	CA2443835A1 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	CA2443719A1 Human fibroblast growth factor-related compositions
11/07/2002	CA2443625A1 Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer
11/07/2002	CA2442608A1 Crystalline hydrochloride salt of (2r)-anti-5-(3-[-4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl)-2-hydroxypoxy}quinoline
11/07/2002	CA2429001A1 Cysteine protease inhibitors
11/07/2002	CA2408369A1 Substituted indoles as parp inhibitors
11/06/2002	EP1255112A2 Treatment of T-cell mediated diseases
11/06/2002	EP1254953A1 Maturation-promoting agent for immature dendritic cells
11/06/2002	EP1254908A1 Preparation of a camptothecin derivative by intramolecular cyclisation
11/06/2002	EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002	EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002	EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002	EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
11/06/2002	EP1254255A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies
11/06/2002	EP1254251A2 Neurosteroids as markers for alzheimer's disease
11/06/2002	EP1254246A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/06/2002	EP1254242A1 17 human secreted proteins
11/06/2002	EP1254241A2 Phosphatases
11/06/2002	EP1254240A2 Proteins producing an altered immunogenic response and methods of making and using the same
11/06/2002	EP1254239A2 Mammalian secreted group iii phospholipase a2
11/06/2002	EP1254236A2 Drug metabolizing enzymes
11/06/2002	EP1254235A2 Drug metabolizing enzymes
11/06/2002	EP1254229A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
11/06/2002	EP1254225A2 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof
11/06/2002	EP1254224A2 Interferon-alpha induced genes
11/06/2002	EP1254220A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same
11/06/2002	EP1254214A2 Human protein kinases and protein kinase-like enzymes
11/06/2002	EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002	EP1254176A2 Trade molecules and uses related thereto
11/06/2002	EP1254174A2 Human cyr61
11/06/2002	EP1254169A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity
11/06/2002	EP1254162A2 Kahalalide f and related compounds
11/06/2002	EP1254145A1 N,o-amidomalonate platinum complexes
11/06/2002	EP1254143A2 Lipid-based drug delivery systems
11/06/2002	EP1254141A1 Camptothecin -beta-alanine esters with topoisomerase i inibhition
11/06/2002	EP1254140A1 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
11/06/2002	EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
11/06/2002	EP1254137A1 PYRIDO 2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS
11/06/2002	EP1254134A2 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors
11/06/2002	EP1254133A2 Indol-3-yl derivatives
11/06/2002	EP1254132A1 Food product and process
11/06/2002	EP1254131A1 Extraction of flavonoids
11/06/2002	EP1254130A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/06/2002	EP1254124A1 Dipeptide nitrile cathpsin k inhibitors
11/06/2002	EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002	EP1254122A2 Novel 3-substituted 1,2,4-benzotriazines, a method for their production and the use thereof
11/06/2002	EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002	EP1254116A1 Alpha v integrin receptor antagonists
11/06/2002	EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002	EP1254111A1 Novel vitamin d analogues
11/06/2002	EP1254106A1 Calcilytic compounds
11/06/2002	EP1253966A2 Substances and agents for positively influencing collagen
11/06/2002	EP1253942A1 Cd40-binding apc-activating molecules
11/06/2002	EP1253940A2 Low dose haptenized tumor cell and tumor cell extract immunotherapy
11/06/2002	EP1253939A1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent
11/06/2002	EP1253938A2 Immunization of an individual against carcinoma and the preliminary stages thereof
11/06/2002	EP1253931A2 Utilization of protein kinase inhibitor alpha
11/06/2002	EP1253930A2 Method and compositions for treating hepatocellular cancer
11/06/2002	EP1253909A2 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias
11/06/2002	EP1124788A4 Bis(haloethyl)aminobenzene derivatives
11/06/2002	EP1109818B1 Phosphoepoxides, method for making same and uses
11/06/2002	EP1097159B1 Phosphinous and phosphonic acid derivatives used as medicaments
11/06/2002	EP1091966B1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace)
11/06/2002	EP1000038B1 Novel pyrimidin derivatives
11/06/2002	EP0993459B1 Compounds useful for inhibition of farnesyl protein transferase
11/06/2002	EP0981349B1 5-alpha-pregnan-3-beta-ol-20-one sulfate for the treatment of tumours and cns diseases
11/06/2002	EP0981327B1 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
11/06/2002	EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/06/2002	EP0912559B1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors
11/06/2002	EP0909277A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
11/06/2002	EP0901373B1 Alpha v Beta 3 ANTAGONISTS
11/06/2002	EP0812192B1 Benzothiopyranoindazoles antitumor agents
11/06/2002	EP0758335B1 Preparation of a camptothecin derivative by intramolecular cyclisation
11/06/2002	EP0623134B1 Metal complexes of water soluble texaphyrins
11/06/2002	CN1378594A T-cell receptor gamma alternate reading frame protein (TARP) and uses thereof
11/06/2002	CN1378591A Bacterial protection
11/06/2002	CN1378560A Compounds for treatment of infectious and immune system disorders and method for their use
11/06/2002	CN1378552A Novel transcription factor BP1
11/06/2002	CN1378545A Substituted pyrroles as antiproliferative agents for treatment of cancer
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378543A Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
11/06/2002	CN1378541A Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378536A Neutral-cationic lipid for nuelci acid and drug delivery
11/06/2002	CN1378535A 四氢喹啉衍生物 Tetrahydroquinoline derivative
11/06/2002	CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002	CN1378457A Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras

1 ... 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 ... 2211